Skip to main content
JAK-inhibitor safety in adolescents with AD: Long-term analyses reported
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
JAK-inhibitor safety in adolescents with AD: Long-term analyses reported
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Adolescent Medicine
0
0.99
Thromboembolism
0
0.23
Child
0
0.22
Herpes Zoster
0
0.21
Atopic Dermatitis
0
0.98
Pediatric Dermatology
0
0.16
Patient Safety
0
0.15
Skin Cancer
0
0.14
Tuberculosis
0
0.14
Adverse Effects
0
0.11
California
0
0.11
Hospital
0
0.11
Opportunistic Infection
0
0.11
Nonmelanoma Skin Cancer
0
0.1
Venous Thromboembolism (VTE)
0
0.1
Retinal Diseases
0
0.08
Board Certification
0
0.07
Cancer
0
0.07
Cardiovascular Risk Management
0
0.06
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.8
Pediatrics
0
0.7
Internal Medicine
0
0.9
Rheumatology
0
0.6
Edit Tags